{"TopicDetails": {"type": 0, "ccm2Id": 31073861, "cftId": 0, "identifier": "IMI2-2015-07-05", "title": "A COMPREHENSIVE \u2018PAEDIATRIC PRECLINICAL POC PLATFORM\u2019 TO ENABLE CLINICAL MOLECULE DEVELOPMENT FOR CHILDREN WITH CANCER", "publicationDateLong": 1450396800000, "callIdentifier": "H2020-JTI-IMI2-2015-07-two-stage", "callTitle": "H2020-JTI-IMI2-2015-07-two-stage", "callccm2Id": 31073864, "allowPartnerSearch": true, "workProgrammepart": {"id": 3051, "ccm_id": 31078048, "wp_part": "H2020-JTI-IMI-2016", "wp_year": "H2020-JTI-IMI-2016", "wp_title": "IMI2 Work Plan 2016", "wp_website": "http://www.imi.europa.eu/", "wp_document": "http://ec.europa.eu/research/participants/data/ref/h2020/other/wp/jtis/h2020-wp16-imi_en.pdf"}, "frameworkProgramme": {"id": 31045243, "abbreviation": "H2020", "description": "Horizon 2020 Framework Programme"}, "programmeDivision": [{"id": 31047894, "abbreviation": "EU.3.1.", "description": "Health, demographic change and wellbeing"}, {"id": 31047893, "abbreviation": "EU.3.", "description": "Societal Challenges"}, {"id": 31045244, "abbreviation": "EC", "description": "EC Treaty"}], "topicMGAs": [], "tags": ["animal models", "informatic infrastructure", "testing of compounds", "pre-clinical models", "patient selection"], "keywords": ["Drug development, clinical phases", "Clinical data", "Anticancer therapy", "Safety Pharmacology", "Patient safety", "Tissue banks", "Biomarkers", "Cancer and its biological basis", "Clinical information", "Translational medicine", "Quality-of-life", "Animal biotechnology", "Oncology", "Paediatrics"], "sme": false, "actions": [{"status": {"id": 31094503, "abbreviation": "Closed", "description": "Closed"}, "types": [{"typeOfAction": "IMI2-RIA Research and Innovation action", "typeOfMGA": []}], "plannedOpeningDate": "18 December 2015", "submissionProcedure": {"id": 31094505, "abbreviation": "two-stage", "description": "two-stage"}, "deadlineDates": ["17 March 2016", "06 September 2016"]}], "latestInfos": [], "budgetOverviewJSONItem": {"budgetTopicActionMap": {"3226318": [{"action": "IMI2-2015-07-03 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "18 December 2015", "deadlineModel": "two-stage", "deadlineDates": ["17 March 2016", "06 September 2016"], "budgetYearMap": {"2015": 93604000}, "budgetTopicActionMap": {}}, {"action": "IMI2-2015-07-07 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "18 December 2015", "deadlineModel": "two-stage", "deadlineDates": ["17 March 2016", "06 September 2016"], "budgetYearMap": {"2015": 93604000}, "budgetTopicActionMap": {}}, {"action": "IMI2-2015-07-02 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "18 December 2015", "deadlineModel": "two-stage", "deadlineDates": ["17 March 2016", "06 September 2016"], "budgetYearMap": {"2015": 93604000}, "budgetTopicActionMap": {}}, {"action": "IMI2-2015-07-01 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "18 December 2015", "deadlineModel": "two-stage", "deadlineDates": ["17 March 2016", "06 September 2016"], "budgetYearMap": {"2015": 93604000}, "budgetTopicActionMap": {}}, {"action": "IMI2-2015-07-04 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "18 December 2015", "deadlineModel": "two-stage", "deadlineDates": ["17 March 2016", "06 September 2016"], "budgetYearMap": {"2015": 93604000}, "budgetTopicActionMap": {}}, {"action": "IMI2-2015-07-05 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "18 December 2015", "deadlineModel": "two-stage", "deadlineDates": ["17 March 2016", "06 September 2016"], "budgetYearMap": {"2015": 93604000}, "budgetTopicActionMap": {}}, {"action": "IMI2-2015-07-06 - IMI2-CSA Coordination & support action", "plannedOpeningDate": "18 December 2015", "deadlineModel": "two-stage", "deadlineDates": ["17 March 2016", "06 September 2016"], "budgetYearMap": {"2015": 93604000}, "budgetTopicActionMap": {}}]}, "budgetYearsColumns": ["2015"]}, "description": "<SPAN class=\"topicdescriptionkind\">Specific Challenge</SPAN>:<p>Paediatric cancer:</p><p>20% of all paediatric cancer remains incurable</p><p>Long term side effects associated with treatment</p><p>Cancer is often much more advanced, i.e., metastatic, in children then adults</p><p>Effective and safe treatments are urgently needed</p>\n<SPAN class=\"topicdescriptionkind\">Scope</SPAN>:<p>Build a comprehensive translational network of PDX models, matching cell lines/organoids and genetically modified mouse models with complete molecular characterization and proven relevance to major solid paediatric tumours.</p>\n<SPAN class=\"topicdescriptionkind\">Expected Impact</SPAN>:<p>Increasing the number of cures across a wide range of paediatric cancer histologies (more lives saved);</p><p>Potentially mitigating the long term health effects typically associated with conventional chemotherapeutic, better quality of life</p>\n", "conditions": "<p>Please read carefully all provisions below before the preparation of your application.</p>\r\n<p>You can access the <strong>description of the different topics</strong> in the <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/call_fiches/jtis/h2020-call-fiche15-7-imi2-ju_en.pdf\">Call topics text</a>.</p>\r\n<p>The <strong>budget breakdown</strong> for this Call is given at the end of the Call topics text, in the <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/call_fiches/jtis/h2020-call-fiche15-7-imi2-ju_en.pdf\">Call Conditions</a> section (page 78), as well as the following information :&nbsp;<br />\r\n&nbsp;</p>\r\n<ol>\r\n    <li><strong><span style=\"color: rgb(0,51,102)\">List of countries and applicable rules for funding</span></strong><br />\r\n    &nbsp;</li>\r\n    <li><strong><span style=\"color: rgb(0,51,102)\">Eligibility and admissibility conditions</span></strong><br />\r\n    &nbsp;</li>\r\n    <li><strong><span style=\"color: rgb(0,51,102)\">Evaluation criteria and procedure, scoring and threshold : </span></strong><span style=\"color: rgb(0,51,102)\">described in the <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/guides_for_applicants/jtis/h2020-guide-pse-imi-ju-v1.2_en.pdf\">IMI</a></span><a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/guides_for_applicants/jtis/h2020-guide-pse-imi-ju-v1.2_en.pdf\">&nbsp;Manual for Submission, Evaluation and Grant award</a><br />\r\n    &nbsp;</li>\r\n    <li><span style=\"color: rgb(0,51,102)\"><strong>Indicative timetable for evaluation and grant agreement</strong></span><br />\r\n    &nbsp;</li>\r\n    <li><strong><span style=\"color: rgb(0,51,102)\">Provisions, proposal templates and evaluation forms for the type(s) of action(s) under this topic:</span></strong><br />\r\n    <br />\r\n    <u>IMI2 Research and Innovation Action (IMI2-RIA) and (IMI2-IA):</u><br />\r\n    <br />\r\n    <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/guides_for_applicants/jtis/h2020-guide-rel-prov-imi-ju_en.pdf\">Summary of the most relevant provisions for participating in IMI2 actions</a><br />\r\n    <a href=\"http://ec.europa.eu/research/participants/portal/doc/call/h2020/imi2-2015-03-01/1635128-imi2_proposal-template_ria-ia_en.pdf\">Standard proposal template</a><br />\r\n    <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/call_ptef/ef/h2020-call-ef-imi2-ria-ia-2016_en.pdf\">Standard evaluation form</a><br />\r\n    <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/mga/jtis/h2020-mga-imi_en.pdf\">IMI2 Model Grant Agreement</a><br />\r\n    <a href=\"http://ec.europa.eu/research/participants/portal/doc/call/h2020/h2020-phc-2015-two-stage/1620124-essential_information_for_clinical_studies_2015callsv2_18082014_en.pdf\">Template for Essential Clinical Trials Information</a><br />\r\n    <br />\r\n    <u>MI2 Coordination and Support Action (IMI2-CSA):</u><br />\r\n    <br />\r\n    <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/guides_for_applicants/jtis/h2020-guide-rel-prov-imi-ju_en.pdf\">Summary of the most relevant provisions for participating in IMI2 actions</a><br />\r\n    <a href=\"http://ec.europa.eu/research/participants/portal/doc/call/h2020/imi2-2015-04-01/1635139-imi2_proposal-template_csa_en.pdf\">     Standard proposal template</a><br />\r\n    <a href=\"http://ec.europa.eu/research/participants/portal/doc/call/h2020/imi2-2015-04-01/1635140-imi2_evaluation-form_csa_en.pdf\">     Standard evaluation form</a><br />\r\n    <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/mga/jtis/h2020-mga-imi_en.pdf\">IMI2 Model Grant Agreement<br />\r\n    </a><a href=\"http://ec.europa.eu/research/participants/portal/doc/call/h2020/h2020-phc-2015-two-stage/1620124-essential_information_for_clinical_studies_2015callsv2_18082014_en.pdf\">Template for Essential Clinical Trials Information</a><br />\r\n    &nbsp;</li>\r\n</ol>\r\n<p>&nbsp;</p>", "supportInfo": "<p>Contact the <strong>IMI&nbsp;Programme Office</strong> : E-mail:<a href=\"mailto:Infodesk@imi.europa.eu\"> Infodesk@imi.europa.eu</a>&nbsp;/ Tel: +32 2 221 81 81<br />\r\n<br />\r\nContact <strong>IMI JU&nbsp;<a href=\"mailto:sofia@imi.europa.eu\">IT Helpdesk</a></strong>&nbsp;&ndash; for IMI2 topics contact the SOFIA IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.<br />\r\n<br />\r\n<a href=\"http://www.imi.europa.eu/content/states-representatives-groups\"><strong>IMI States Representative Group (SRG)</strong></a>&nbsp;&ndash; contact you SRG member for assistance.<br />\r\n<a href=\"http://www.imi.europa.eu/content/partner-search\"><br />\r\n<strong>IMI Partner Search Tool</strong></a>&nbsp;helps you find a partner organisation for your proposal<br />\r\n<strong><br />\r\n<span><a href=\"http://ec.europa.eu/research/participants/portal4/desktop/en/support/national_contact_points.html\">National Contact Points (NCP)</a>&nbsp;-&nbsp;</span></strong><span>contact your NCP for further assistance.<br />\r\n</span><br />\r\n<a href=\"http://een.ec.europa.eu/\"><strong>Enterprise Europe Network</strong></a>&nbsp;&ndash; contact your EEN national contact for advice to businesses with special focus on SMEs. The support includes guidance on the EU research funding<br />\r\n<strong><br />\r\n<span><a href=\"http://ec.europa.eu/research/index.cfm?lg=en&amp;pg=enquiries\">Research Enquiry Service</a></span></strong><span> &ndash; ask questions about</span>.&nbsp;any aspect of European research in general and the EU Research Framework Programmes in particular.<br />\r\n<strong><br />\r\nEthics</strong> &ndash; for compliance with ethical issues, check the information available on the<a href=\"http://ec.europa.eu/research/participants/docs/h2020-funding-guide/cross-cutting-issues/ethics_en.htm\"> Participant Portal</a>&nbsp;, on the&nbsp;<a href=\"http://ec.europa.eu/research/science-society/index.cfm?fuseaction=public.topic&amp;id=1289&amp;lang=1\">Science and Society Portal</a>&nbsp;and in&nbsp;<a href=\"http://ec.europa.eu/euraxess/pdf/brochure_rights/am509774CEE_EN_E4.pdf\"><strong>The European Charter for Researchers and the Code of Conduct for their recruitment<br />\r\n</strong></a><a href=\"http://www.cen.eu/cen/Services/Innovation/Pages/default.aspx\"><br />\r\n<strong>CEN</strong></a> and <a href=\"http://www.cenelec.eu/aboutcenelec/whatwestandfor/fosterinnovation/randd.html\"><strong>CENELEC</strong></a>, the European Standards Organisations, advise you how to tackle standardisation in your project proposal. Contact CEN-CENELEC Research Helpdesk at <a href=\"mailto:research@cencenelec.eu\">research@cencenelec.eu</a>.<br />\r\n<a href=\"http://ec.europa.eu/euraxess/pdf/brochure_rights/am509774CEE_EN_E4.pdf\"><br />\r\n</a></p>", "links": [{"callIdentifier": "H2020-JTI-IMI2-2015-07-two-stage-1", "status": "Closed", "criterionType": "SubFundingScheme", "criterionTypeDescription": "subfunding schemes", "criterionCode": "IMI2-RIA", "criterionDescription": "Research and Innovation action", "url": "https://sofia.imi.europa.eu/Pages/Default.aspx", "startDate": "Dec 23, 2015 2:40:00 PM"}], "additionalDossiers": [], "infoPackDossiers": [], "callDetailsJSONItem": {"latestInfos": [{"approvalDate": "Dec 23, 2015 2:48:52 PM", "lastChangeDate": "Dec 23, 2015 2:48:52 PM", "content": "The submission session is now available for: IMI2-2015-07-01(IMI2-RIA), IMI2-2015-07-02(IMI2-RIA), IMI2-2015-07-03(IMI2-RIA), IMI2-2015-07-04(IMI2-RIA), IMI2-2015-07-05(IMI2-RIA), IMI2-2015-07-06(IMI2-RIA), IMI2-2015-07-07(IMI2-RIA)"}], "hasForthcomingTopics": false, "hasOpenTopics": false, "allClosedTopics": true}}}